The Oncolytic Virus Therapy market is estimated to be valued at US$ 9.39 million in 2023 and is expected to exhibit a CAGR of 25.1% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Oncolytic virus therapy is a novel approach to treating cancer that uses genetically modified viruses to selectively target and destroy cancer cells while sparing healthy cells. ... Read more
